Chickenpox Vaccine Market Demand Likely to Propel by Rise in
Drug Development Activities in Upcoming Years
According to a recently published report by Research Nester on “Global
Chickenpox
(Varicella)
Vaccine
Market
Outlook:
Industry
Insights & Opportunity Assessment 2019-2027” delivers detailed
overview of the global chickenpox (varicella) vaccine market in terms of
market segmentation by product type, product application and by region.
Further, for the in-depth analysis, the report encompasses the industry
growth drivers, restraints, supply and demand risk, market attractiveness,
BPS analysis and Porter’s five force model.
With growing awareness towards vaccination against chickenpox, there is an
increase in demand for chickenpox (varicella) vaccine. One dose of vaccine
prevents 95% of moderate disease and 100% of several diseases. Two doses
of vaccine are more effective than one. If it is given to those who are not
immune within five days of exposure to chickenpox, it prevents most cases
of diseases. Vaccinating a large population means protecting even those who
are not vaccinated. Vaccines for chickenpox is mostly given in combination
vaccines which helps to prevent three diseases together which is estimated
to boost the growth of the chickenpox (varicella) vaccine market with a CAGR
of 7.8% during the period 2019-2027.
The global chickenpox (varicella) vaccine market is segmented by product
type and product application. By product type, the combination vaccine
segment is expected to hold major share over the forecast period. The
demand for combination vaccine has gathered pace attributing to the fact
that this vaccine helps to prevent three diseases together.